Literature DB >> 30064010

Changes in synaptic AMPA receptor concentration and composition in chronic temporal lobe epilepsy.

Daniel L Egbenya1, Suleman Hussain1, Yi-Chen Lai2, Jun Xia3, Anne E Anderson2, Svend Davanger4.   

Abstract

Excitotoxicity caused by excessive stimulation of glutamate receptors, resulting in pathologically increased Ca2+-concentrations, is a decisive factor in neurodegenerative diseases. We investigated long-term changes in synaptic contents of AMPA receptor subunits that play important roles in calcium regulation in chronic epilepsy. Such plastic changes may be either adaptive or detrimental. We used a kainic acid (KA)-based rat model of chronic temporal lobe epilepsy (TLE). Using hippocampal synaptosomes, we found significant reductions in the concentration of the AMPA receptor subunits GluA1 and GluA2, and the NMDA receptor subunit NR2B. The relative size of GluA1 and GluA2 reductions were almost identical, at 28% and 27%, respectively. In order to determine whether the synaptic reduction of the AMPA receptor subunits actually reflected the pool of receptors present along the postsynaptic density (PSD), as opposed to cytoplasmic or extrasynaptic pools, we performed postembedding immunogold electron microscopy (EM) of GluA1 and GluA2 in Schaffer collateral synapses in the hippocampal CA1 area. We found significant reductions, at 32% and 52% of GluA1 and GluA2 subunits, respectively, along the PSD, indicating that these synapses undergo lasting changes in glutamatergic neurotransmission during chronic TLE. When compared to the overall concentration and composition of AMPA receptors expressed in the brain, there was a relative increase in GluA2-lacking AMPA receptor subunits following chronic epilepsy. These changes in synaptic AMPA receptor subunits may possibly contribute to further aggravate the excitotoxic vulnerability of the neurons as well as have significant implications for hippocampal cognitive functions.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  AMPA receptor; Chronic TLE; Electron microscopy; Excitotoxicity; Synapse; Western blotting

Mesh:

Substances:

Year:  2018        PMID: 30064010     DOI: 10.1016/j.mcn.2018.07.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  10 in total

Review 1.  Autoimmune seizures and epilepsy.

Authors:  Christian Geis; Jesus Planagumà; Mar Carreño; Francesc Graus; Josep Dalmau
Journal:  J Clin Invest       Date:  2019-02-04       Impact factor: 14.808

2.  Inhibition of microRNA-34a Suppresses Epileptiform Discharges Through Regulating Notch Signaling and Apoptosis in Cultured Hippocampal Neurons.

Authors:  Jinli Wang; Yuan Zheng; Xu Cheng; Fenfen Xu; Piaopiao Zhang; Xiao Zhou; Hongyang Zhao
Journal:  Neurochem Res       Date:  2019-03-15       Impact factor: 3.996

3.  Changes in excitatory and inhibitory receptor expression and network activity during induction and establishment of epilepsy in the rat Reduced Intensity Status Epilepticus (RISE) model.

Authors:  Hope I Needs; Benjamin S Henley; Damiana Cavallo; Sonam Gurung; Tamara Modebadze; Gavin Woodhall; Jeremy M Henley
Journal:  Neuropharmacology       Date:  2019-07-26       Impact factor: 5.250

4.  Src/CK2/PTEN-Mediated GluN2B and CREB Dephosphorylations Regulate the Responsiveness to AMPA Receptor Antagonists in Chronic Epilepsy Rats.

Authors:  Ji-Eun Kim; Duk-Shin Lee; Hana Park; Tae-Cheon Kang
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 5.  Synaptic Reshaping and Neuronal Outcomes in the Temporal Lobe Epilepsy.

Authors:  Elisa Ren; Giulia Curia
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

6.  Absence of RNA-binding protein FXR2P prevents prolonged phase of kainate-induced seizures.

Authors:  Adrian C Lo; Nicholas Rajan; Denise Gastaldo; Ludovic Telley; Muna L Hilal; Andrea Buzzi; Michele Simonato; Tilmann Achsel; Claudia Bagni
Journal:  EMBO Rep       Date:  2021-03-28       Impact factor: 8.807

7.  PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats.

Authors:  Ji-Eun Kim; Hana Park; Ji-Eun Lee; Tae-Hyun Kim; Tae-Cheon Kang
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

8.  Levetiracetam Reduced the Basal Excitability of the Dentate Gyrus without Restoring Impaired Synaptic Plasticity in Rats with Temporal Lobe Epilepsy.

Authors:  Guillermo González-H; Itzel Jatziri Contreras-García; Karla Sánchez-Huerta; Claudio M T Queiroz; Luis Ricardo Gallardo Gudiño; Julieta G Mendoza-Torreblanca; Sergio R Zamudio
Journal:  Brain Sci       Date:  2020-09-11

Review 9.  Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy.

Authors:  Roberta Celli; Francesco Fornai
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

10.  Reelin Regulates Neuronal Excitability through Striatal-Enriched Protein Tyrosine Phosphatase (STEP61) and Calcium Permeable AMPARs in an NMDAR-Dependent Manner.

Authors:  Murat S Durakoglugil; Catherine R Wasser; Connie H Wong; Theresa Pohlkamp; Xunde Xian; Courtney Lane-Donovan; Katja Fritschle; Lea Naestle; Joachim Herz
Journal:  J Neurosci       Date:  2021-07-21       Impact factor: 6.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.